Abstract
The repair of musculoskeletal tissues has posed a constant challenge for orthopaedic surgeons, and the occurrence of bone and cartilage injuries is expected to increase with the aging of the world population. To overcome the limitations of current treatments, tissue engineering enhanced through gene therapy is garnering significant interest as a promising new alternative. This paper reviews the essential factors involved in tissue engineering, including the appropriate cell source, inductive agents, scaffolds, and mechanical stimulation. Particular emphasis is placed on the use of muscle-derived stem cells that can be genetically engineered to deliver growth factors to the site of injury and initiate the formation of new bone and cartilage. These same gene-carrying cells may also serve as a source of progenitor cells for bone and cartilage formation, making muscle-based gene therapy and tissue engineering a potential treatment for cartilage and bone defects.
Keywords: tissue engineering, gene therapy, mdsc, bone, cartilage, bmps
Current Genomics
Title: Muscle-Based Gene Therapy and Tissue Engineering for Cartilage and Bone Healing
Volume: 5 Issue: 1
Author(s): K. Corsi, G. H. Li, H. Peng and J. Huard
Affiliation:
Keywords: tissue engineering, gene therapy, mdsc, bone, cartilage, bmps
Abstract: The repair of musculoskeletal tissues has posed a constant challenge for orthopaedic surgeons, and the occurrence of bone and cartilage injuries is expected to increase with the aging of the world population. To overcome the limitations of current treatments, tissue engineering enhanced through gene therapy is garnering significant interest as a promising new alternative. This paper reviews the essential factors involved in tissue engineering, including the appropriate cell source, inductive agents, scaffolds, and mechanical stimulation. Particular emphasis is placed on the use of muscle-derived stem cells that can be genetically engineered to deliver growth factors to the site of injury and initiate the formation of new bone and cartilage. These same gene-carrying cells may also serve as a source of progenitor cells for bone and cartilage formation, making muscle-based gene therapy and tissue engineering a potential treatment for cartilage and bone defects.
Export Options
About this article
Cite this article as:
Corsi K., Li H. G., Peng H. and Huard J., Muscle-Based Gene Therapy and Tissue Engineering for Cartilage and Bone Healing, Current Genomics 2004; 5 (1) . https://dx.doi.org/10.2174/1389202043490005
DOI https://dx.doi.org/10.2174/1389202043490005 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
Current Drug Targets Tumor Stroma Manipulation By MSC
Current Drug Targets Novel Orphan Nuclear Receptors-Coregulator Interactions Controlling Anti-Cancer Drug Metabolism
Current Drug Metabolism The Cross-over of Anticancer Agents with Osteoclast Activities
Current Cancer Therapy Reviews Post-menopausal Osteoporosis and Probiotics
Current Drug Targets CD248: Reviewing its Role in Health and Disease
Current Drug Targets A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Multifaceted Role of Neuropilins in Cancer
Current Medicinal Chemistry Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics
Current Topics in Medicinal Chemistry YB-1 Activities in Oncogenesis: Transcription and Translation
Current Cancer Therapy Reviews Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
Current Protein & Peptide Science Pharmacogenetics of Phase I and Phase II Drug Metabolism
Current Pharmaceutical Design Ruthenium(II) Complexes as Potential Apoptosis Inducers in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Role of Angiopoietin-like 4 (ANGPTL4), a Member of Matricellular Proteins: from Homeostasis to Inflammation and Cancer Metastasis
Current Angiogenesis (Discontinued) Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry Follow the ATP: Tumor Energy Production: A Perspective
Anti-Cancer Agents in Medicinal Chemistry Recent Results on A-Ring Modification of 1α,25-Dihydroxyvitamin D3: Design and Synthesis of VDR-Agonists and Antagonists with High Biological Activity
Current Topics in Medicinal Chemistry Ewing’s Sarcoma Cancer Stem Cell Targeted Therapy
Current Stem Cell Research & Therapy